跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRIVA-DONEPEZIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRIVA-DONEPEZIL
Authorized
STANDARD
PRIVA-DONEPEZIL
pharmapar inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bb0eaa96e47182fd
Company
pharmapar inc
Type
Standard
Approval Details
Approval Id
bb0eaa96e47182fd
Drug Approval Canada Name
PRIVA-DONEPEZIL
Product Name
PRIVA-DONEPEZIL
Status
Cancelled Post Market
Status Date
2022-07-29
Original Market Date
2020-12-11
Din
02446669
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
12:04.00
Atc Original
N06DA02 DONEPEZIL
Atc Name
n 06 da 02
Aig Number
0131548001
Company Name
pharmapar inc
Company Address
1565 Boul Lionel-Boulet, Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
DONEPEZIL HYDROCHLORIDE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bb0eaa96e47182fd
Type
Standard
Back to Health Canada Approvals